跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 255 条关于
“Prurigo Nodularis”
全部
255
临床试验
177
药物
1
机构
9
资讯
68
去年
Advancements in Atopic Dermatitis and Prurigo Nodularis Therapies Highlighted at Fall Clinical 2024
2年前
FDA Approves Galderma's Nemolizumab (Nemluvio) for Prurigo Nodularis
去年
Shared Pathophysiology Drives Therapeutic Advances in Prurigo Nodularis and Atopic Dermatitis
去年
Ruxolitinib Cream Shows Promising Results in First Phase 3 Trials for Prurigo Nodularis
9个月前
InnoCare Initiates Global Phase II Trial of TYK2 Inhibitor Soficitinib for Prurigo Nodularis Treatment
去年
Nemolizumab Shows Long-Term Efficacy in Atopic Dermatitis and Prurigo Nodularis
2年前
FDA Approves Galderma's Nemluvio as First IL-31 Inhibitor for Prurigo Nodularis
去年
Galderma's Phase III OLYMPIA 1 Trial Results Show Nemolizumab Significantly Improves Prurigo Nodularis Symptoms
12天前
Chugai's Nemolizumab Research Honored with 11th JBDA Award for Drug Discovery
9个月前
Galderma Initiates Phase II Trial of Nemolizumab for Chronic Pruritus of Unknown Origin
第 1 页,共 7 页
上一页
下一页